Clara reads your A1C trajectory, your medication list, your kidney function, and your prior diabetes Rx history before drafting a starting dose. A physician signs off on every Rx.
Get started How it worksValues and scenarios shown are illustrative examples only. All clinical assessments are individualized and reviewed by a licensed physician.
Clara auto-syncs your medical records from 150,000+ doctors' offices, hospitals, labs, and pharmacies: every prior lab, every prescription, every diagnosis. Wearable data syncs automatically on Standard and Concierge plans. Free to start, no credit card.
Before drafting any prescription, Clara reads your full chart: indication, contraindications, every drug and supplement on your list, and any prior trials of this medication. The interaction check runs against the full FDA label — not just the common flagged pairs.
Every prescription is reviewed and signed off by a licensed physician before it reaches your pharmacy. Clara then tracks the key monitoring labs on schedule — not at your next annual visit — and flags when dose adjustment or follow-up is warranted.
Connect your records and let Clara read your full chart before a prescription is ever drafted.
Get started Free to connect records. HSA and FSA eligible.Clara reads your A1C trajectory, your fasting glucose, your prior anti-diabetic medications, and your kidney function before confirming Mounjaro candidacy. It cross-checks your personal and family history for medullary thyroid carcinoma or MEN 2 syndrome — both contraindications — before drafting.
Mounjaro delays gastric emptying and can alter absorption of co-administered oral medications. Co-administration with insulin or sulfonylureas increases the risk of hypoglycemia, often requiring a dose reduction of the concomitant drug. Tirzepatide may reduce the efficacy of oral contraceptives at therapy initiation and after dose escalation; the label recommends a non-oral backup contraceptive method for 4 weeks after initiation and after each dose increase.
Per the Mounjaro prescribing information, the starting dose is 2.5 mg subcutaneously once weekly for 4 weeks (for tolerance, not glycemic control), then 5 mg weekly. Dose may be increased in 2.5 mg increments after at least 4 weeks at the current dose, up to a maximum of 15 mg weekly.1
Clara prompts an A1C recheck at 3 months after starting Mounjaro or any dose change. Renal function is monitored during dose escalation and with volume-depletion symptoms. Patients on insulin or sulfonylureas are reviewed for hypoglycemia throughout titration.
Tirzepatide (Mounjaro) is a prescription medication. The following is a summary of key safety information from the FDA-approved prescribing information. This is not a complete list — see the full prescribing information linked in the footer.
In rodent studies, tirzepatide caused thyroid C-cell tumors. It is unknown whether Mounjaro causes such tumors in humans. Mounjaro is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Acute pancreatitis (discontinue if suspected). Acute kidney injury (especially with dehydration from GI side effects). Hypoglycemia when used with insulin or sulfonylureas. Diabetic retinopathy complications in patients with a history of retinopathy. Acute gallbladder disease. Hypersensitivity reactions. Reduced efficacy of oral contraceptives at initiation and dose escalation. The most common adverse reactions are nausea, diarrhea, decreased appetite, vomiting, constipation, abdominal pain, and dyspepsia.
A1C at baseline and every 3 months until at goal. Renal function during dose escalation and with volume-depletion symptoms. Patients on insulin or sulfonylureas should be monitored for hypoglycemia. Patients with a history of diabetic retinopathy should have ophthalmic monitoring.
Pregnancy: discontinue Mounjaro when pregnancy is recognized; tirzepatide may cause fetal harm based on animal data. Lactation: limited data; consider risks and benefits. Pediatric: safety and effectiveness in pediatric patients have not been established. Geriatric: no overall dose adjustment, but increased monitoring is reasonable. Renal/hepatic impairment: no dose adjustment recommended.
| Clara | Cash-pay DTC GLP-1 telehealth | General telehealth | Your doctor | |
|---|---|---|---|---|
| Cost to start | Free (records + chat) | Subscription required | Per-visit fee | $150+ copay |
| Monthly cost | From $25/mo · Standard $50/mo · HSA/FSA eligible | $199–$299/mo bundled cash-pay | Per-visit, varies | Per-visit copay |
| Reads full chart before prescribing | ✓ Auto-synced, 150,000+ sources | Intake questionnaire only | Self-uploaded only | Within a single practice |
| Prescribes FDA-approved branded medication (not compounded) | ✓ Branded | Often compounded tirzepatide | Varies | ✓ |
| Prescription may be covered by your insurance | ✓ | Cash-pay bundled | Varies | ✓ |
| On-schedule A1C and kidney monitoring | ✓ Ordered on label cadence | Patient-initiated | Patient-initiated | At next visit |
| Biomarker panel included | ✓ 74–108 tests in membership | Extra cost | Extra cost | Per-test copay |
| Full primary care (beyond diabetes) | ✓ | Single-vertical | Single-condition | ✓ |
Full chart read before the first prescription. On-schedule labs after every dose change.
Get started Standard $50/mo · Concierge $150/mo · HSA/FSA eligible.A clinician in a 15-minute visit reads the last panel. Clara reads every result you've ever had drawn — every lab, every wearable reading, every medication change — and cross-references them in a single pass. That's not a time-management difference. It's a category-of-work difference. The AI handles the data; licensed physicians handle every clinical decision.
Clara auto-syncs from 150,000+ medical sources and reads every prior result, medication, and diagnosis together — not just the last visit's notes. Pattern-finding across years of data is what the AI is built for.
Clara watches for drift between visits — a creeping lab value, a wearable trend, a new medication interaction — and surfaces it when it's actionable, not when you happen to schedule an appointment.
Clara drafts; physicians decide. Every prescription and lab order is reviewed and signed by a licensed clinician before it reaches your pharmacy or lab. The AI handles intake, reasoning, and follow-up. The physician handles sign-off.
An AI that reads your full chart. A physician who signs off on every clinical decision.
Get started Licensed medical providers review every prescription and lab order.Free to connect your records and chat with Clara. Standard and Concierge plans include physician-reviewed prescriptions, on-schedule lab monitoring, and bundled biomarker panels.
Get started